Abstract
Primary pulmonary hypertension (PPH) associated with pregnancy carries a high maternal mortality rate. Short-term epoprostenol infusion has been demonstrated to improve the hemodynamic profile in patients with PPH. We report a successful maternal-fetal outcome with epoprostenol therapy during pregnancy, cesarean section, and postpartum in a patient with PPH. Epoprostenol therapy did not produce any physical or developmental abnormalities in the fetus. A favorable maternal-fetal outcome may occur with a multidisciplinary approach.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 973-975 |
| Number of pages | 3 |
| Journal | Chest |
| Volume | 119 |
| Issue number | 3 |
| DOIs | |
| State | Published - 2001 |
Keywords
- Cesarean section
- Epoprostenol
- Pregnancy
- Pulmonary hypertension
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine
- Critical Care and Intensive Care Medicine
- Cardiology and Cardiovascular Medicine